Rapid Micro Biosystems (NASDAQ:RPID) Rating Lowered to “Sell” at Wall Street Zen

Rapid Micro Biosystems (NASDAQ:RPID) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday.

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Thursday, January 22nd. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, Rapid Micro Biosystems has a consensus rating of “Hold” and a consensus target price of $8.00.

Rapid Micro Biosystems Price Performance

Rapid Micro Biosystems stock opened at $2.27 on Friday. The stock has a market cap of $103.19 million, a price-to-earnings ratio of -2.12 and a beta of 1.59. The company has a current ratio of 3.31, a quick ratio of 2.36 and a debt-to-equity ratio of 0.57. The company’s 50-day moving average price is $3.59 and its two-hundred day moving average price is $3.52. Rapid Micro Biosystems has a 52 week low of $1.86 and a 52 week high of $4.94.

Rapid Micro Biosystems (NASDAQ:RPID) last released its quarterly earnings results on Thursday, March 12th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.05). The company had revenue of $11.28 million for the quarter, compared to the consensus estimate of $10.93 million. Rapid Micro Biosystems had a negative return on equity of 95.40% and a negative net margin of 140.30%. On average, analysts expect that Rapid Micro Biosystems will post -1.1 EPS for the current fiscal year.

Insider Buying and Selling at Rapid Micro Biosystems

In other news, CFO Sean M. Wirtjes sold 7,480 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $4.32, for a total transaction of $32,313.60. Following the completion of the transaction, the chief financial officer owned 556,194 shares in the company, valued at approximately $2,402,758.08. This trade represents a 1.33% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO John J. Addington Wilson sold 9,603 shares of Rapid Micro Biosystems stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $4.32, for a total transaction of $41,484.96. Following the completion of the transaction, the chief operating officer directly owned 316,762 shares in the company, valued at $1,368,411.84. This represents a 2.94% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 249,705 shares of company stock valued at $1,021,364 over the last 90 days. Insiders own 29.96% of the company’s stock.

Institutional Trading of Rapid Micro Biosystems

A number of large investors have recently added to or reduced their stakes in RPID. Evernest Financial Advisors LLC increased its holdings in shares of Rapid Micro Biosystems by 355.1% in the third quarter. Evernest Financial Advisors LLC now owns 200,234 shares of the company’s stock valued at $669,000 after buying an additional 156,234 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Rapid Micro Biosystems by 6.3% during the 4th quarter. Geode Capital Management LLC now owns 217,568 shares of the company’s stock valued at $631,000 after acquiring an additional 12,881 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Rapid Micro Biosystems by 6.7% during the 3rd quarter. Vanguard Group Inc. now owns 965,018 shares of the company’s stock worth $3,223,000 after acquiring an additional 60,655 shares in the last quarter. 683 Capital Management LLC acquired a new position in shares of Rapid Micro Biosystems in the 4th quarter worth $350,000. Finally, Jane Street Group LLC grew its holdings in shares of Rapid Micro Biosystems by 176.1% in the 4th quarter. Jane Street Group LLC now owns 105,301 shares of the company’s stock worth $305,000 after acquiring an additional 67,161 shares during the last quarter. 52.60% of the stock is currently owned by institutional investors.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.